BioMarin Pharmaceutical Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

NOVATO, Calif., July 25, 2012 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced that on July 16, 2012, the compensation committee of BioMarin's board of directors approved the grant to two employees of stock options to purchase 13,400 shares of common stock in the aggregate and the grant of 1,310 restricted stock units to one of the employees. The stock options and restricted stock units were granted pursuant to the BioMarin Pharmaceutical Inc. 2012 Inducement Plan, approved by the compensation committee of BioMarin's board of directors on May 8, 2012 and as inducements material to the new employees entering into employment with BioMarin in accordance with NASDAQ Listing Rule 5635(c)(4).